HOME >> BIOLOGY >> NEWS
The 'female advantage' in kidney disease does not extend to diabetic women

en with diabetes are more likely to get kidney disease than their non-diabetic female counterparts, the Georgetown researchers conducted several studies in which they determined that:

  • diabetes is associated with reduced estrogen (estradiol) levels, which may explain why the females lose the protective factor when it comes to diabetes

  • estrogen and estrogen-like supplements protect the kidney in an animal model of diabetic renal disease, suggesting that restoring estrogen levels provides protection against kidney disease

  • the absence of the hormone testosterone contributes to a more rapid progression of kidney disease when diabetes is present. More severe renal damage can be found when diabetes is present.

Conclusion

These findings suggest that sex hormones play a significant role in the development of diabetic kidney disease. According to Maric, "Our observations suggest that kidney disease in diabetic women may not be the result of absolute levels of hormones, as previously thought, but to the relative ratio of [sex hormone] androgen to estrogen. It may well be that the ratio of the two hormones is what determines the effect of the hormones in the diabetic kidney."

According to Dr. Maric, "The biggest surprise has been the finding that sex hormones -- normally thought to control only the reproductive function -- are involved in controlling processes in non-reproductive organs, including the kidney. Moving forward, we need to look more deeply into understanding how sex hormones affect organ function in each gender."


'"/>

Contact: Donna Krupa
dkrupa@the-aps.org
301-634-7209
American Physiological Society
8-Aug-2007


Page: 1 2

Related biology news :

1. A gene that protects from kidney disease
2. Chinese medicinal compound stops formation of cysts in polycystic kidney disease in lab
3. Adult stem/progenitor cells repair of damaged brain, pancreas, kidney cells newly understood
4. New reference material for diagnosing kidney disease
5. Triptolide: A potential drug for polycystic kidney disease
6. Nicotine: The link between cigarette smoking and kidney disease progression?
7. Proteins effects essential for kidney-to-bladder urine transfer
8. UVA receives training grant for new kidney disease researchers
9. Mutant gene causes severe kidney disease in infants
10. Convening kidney health in Copenhagen
11. Treatment disconnect in kidney cancer: Rising mortality despite more small tumors, more surgery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The female advantage kidney disease does not extend diabetic women

(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:4/1/2015)... 2015   Medisafe ™, the leading global medication ... iOS and Android smartphones and tablets, ... the platform to allow patients to track and correlate ... time, patients will be able to visualize in real-time ... biometrics, such as glucose levels and blood pressure. ...
(Date:3/31/2015)... 2015  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ... Software Defined Network Architecture (ET Software DNA® 2.0) platforms ... approximately $20.4 million for the year ended December 31, ... the year ended December 31, 2013. ... completed its multi-year transition away from its legacy landline ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
(Date:4/1/2015)... and NEW YORK , ... (NASDAQ:  PTBI), a biopharmaceutical company advancing protein biologic ... an overview of the Company,s 2014 achievements and ... below demonstrate the progress the Company has made ... corporate partnerships for its MuGard programs, the FDA ...
(Date:4/1/2015)... Holomic is introducing the HRDR-400, the ... and fluorescent rapid tests with one device. , ... readers and is already selling its HRDR-200 chromatographic and ... of its kind offering for manufacturers and end-users that ... Neven Karlovac, CEO of Holomic LLC, commented, "We are ...
(Date:4/1/2015)... and LONDON , April 1, ... reports and solutions, MarketResearch.com is pleased to highlight a report ... year of market growth and opportunity for the stem cell ... or cord blood bank, competing in the stem cell marketplace ... industry trends, and act on market changes before the competition. ...
(Date:4/1/2015)... Earlier this year, A.J. O’Connor Associates ... that represents research-based life science organizations in New Jersey, ... Vice President of Business Development & Executive Coach, attended ... attracted over 750 attendees. , In one of ... cancer survivor shared his moving story of how, almost ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4HR Consulting Firm, A.J. O'Connor Associates Joins BioNJ – The Vibrant 400 Member Strong Life Sciences Industry Association - and Attends its Annual Dinner 2
Cached News: